Skip to main content

Table 1 Each parameter of the 18 patients who fulfilled the inclusion criteria

From: Bone turnover markers to assess jawbone quality prior to dental implant treatment: a case-control study

Case no. Gender Age [years] Bone turnover marker Position Implant Bone Density [HU] Follow-up period [m] Marginal bone loss [mm]
OC BAP ICTP NTX
1 M 60.2 5.8 8.1 2.7 11.4 7┐ SLA 1112.63 10 -
        6┐ SLA 815.75 10 -
2 M 51.3 4.9 9.9 3.0 12.0 6┐ SLA 746.00 6 0.32
        5┐ SLA 893.55 6 0.12
        ┌5 SLA 861.52 19 0.13
        ┌6 SLA 549.77 19 0.00
        ┌7 SLA 415.24 19 0.07
3 M 64.3 3.5 8.7 2.4 12.9 ┌6 SLA 593.45 36 0.39
4 M 54.0 4.8 11.6 2.6 - ┌7 SLA 2001.55 19 -
5 M 60.8 5.2 13.3 2.8 9.8 7┐ Mk-III 530.18 24 0.26
        6┐ Mk-III 853.68 24 0.40
        5┐ Mk-III 951.56 24 0.27
        ┌6 Mk-III 563.19 24 0.88
        ┌7 Mk-III 595.82 24 0.80
6 F 58.1 8.8 14.2 2.2 14.0 4┐ Mk-III 1138.26 21 1.14
        6┐ Mk-III 1012.40 21 1.09
7 M 53.4 3.3 13.3 3.0 15.4 7┐ Mk-III 1070.54 48 0.33
        6┐ Mk-III 1213.59 48 0.58
8 F 51.2 4.2 11.6 2.7 10.4 7┐ Mk-III 898.31 20 0.61
        6┐ Mk-III 782.95 20 0.94
9 M 62.5 5.2 13.1 2.4 12.8 5┐ Mk-III 761.43 6 0.18
10 F 54.3 11.0 23.0 ↑ 3.0 18.2 ↑ ┌6 SLA 400.65 17 0.11
        ┌7 SLA 333.05 17 0.03
11 F 60.3 14.9 ↑ 21.1 ↑ 3.9 12.6 ┌6 SLA 405.96 12 0.20
        ┌7 SLA 15.77 12 0.36
12 F 67.8 4.8 19.4 ↑ 3.6 12.3 ┌4 SLA 1112.42 23 0.39
13 F 75.5 4.1 26.5 ↑ 3.6 16.3 ┌6 SLA 395.40 48 0.03
14 F 58.8 7.8 16.9 ↑ 3.1 18.0 ↑ 7┐ SLA 396.18 8 0.16
        5┐ SLA 502.17 8 0.02
15 F 60.6 6.1 22.2 ↑ 2.9 11.3 6┐ Mk-III 314.49 24 0.32
16 F 64.5 9.4 15.4 ↑ 3.5 21.1 ↑ 4┐ Mk-III 620.43 29 0.80
17 F 63.3 8.1 17.5 ↑ 3.0 15.5 ┌6 Mk-III 734.52 30 1.07
        ┌7 Mk-III 624.92 30 0.99
18 F 63.1 7.8 15.4 ↑ 3.3 22.2 ↑ 6┐ Mk-III 812.32 21 0.94
        5┐ Mk-III 644.81 21 1.11
  1. The normal ranges for BTM values are as follows: OC, 2.5–13.0 ng/ml; BAP, 3.7–20.9 ng/ml for men and 3.9–14.5 ng/ml in women; ICTP, < 4.5 ng/ml; and NTX, 9.5–17.7 ng/ml for men and 7.5–16.5 ng/ml for women
  2. BAP bone alkaline phosphatase, BTM bone turnover marker, HU Hounsfield units, ICTP pyridinoline cross-linked carboxyterminal telopeptide of type I collagen, ISQ implant stability quotient, NTX crosslinked N-telopeptide of type I collagen, SLA sandblasted and acid-etched, internal connection system, OC osteocalcin, Mk-III TiUnite, external connection system